Register

Browse Companies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
0 1 2 3 4 5 6 7 8 9
Top 10 Penny Stocks
Symbol: Price: Chg %: Volume:
SVFC 0.0002 0 776049170
PWEI 0.0002 0 68671609
STLK 0.0002 0 55003461
BBDA 0.0002 -33.33 40073363
PLKD 0.0002 0 37706950
FOGC 0.0002 0 28214668
TADF 0.0002 0 12042000
YTRV 0.0002 0 11849998
DKAM 0.0002 100 10869652
MIKP 0.0002 0 9300718
ENTB 0.0002 -0 7735250
VOYT 0.0002 0 6602546
AVVH 0.0002 0 4000020
PIHN 0.0002 0 3960000
APRU 0.0002 0 3398999
CCTR 0.0002 0 2943486
OTHM 0.0002 0 2100000
PCLI 0.0002 0 1700000
VTPI 0.0002 0 1412511
BTDG 0.0002 0 1205500
BLLB 0.0002 0 900000
TWWI 0.0002 0 895000
BCDH 0.0002 0 820000
BCDH 0.0002 0 820000
VSHC 0.0002 0 800000
CSLI 0.0002 0 775000
UNVC 0.0002 0 700000
BCLE 0.0002 0 552000
MDGC 0.0002 -0 500000
VCTY 0.0002 0 499865

0001 Stocks

Sort By: Date Alphabetically

MultiCell Technologies, Inc. (MCET) Loses Momentum After Recent Climb

Thumbnail
MultiCell Technologies, Inc. (MCET) spiked last Monday after a press release came out, announcing the company had been granted a U.S. patent covering novel drug compositions and platform technologies used for fighting virus infection and cancer. MCET climbed by 57% in price on a 750 thousand share volume at a $846,1 thousand trade value. These were the highest numbers for the company in over five months and the first significant increase since late March. The next day, however, the ticker suffered... more

Bergio International, Inc. (BRGO) Files 10-Q To Report No Progress

Thumbnail
On Thursday, Bergio International, Inc. (BRGO) managed to timely submit its 10-Q for the period ended June 30, 2014. The next day, BRGO issued a press release in which it commented on the results from the report. As can be seen in the filing, the financials did not account for much progress made by the company: Cash: $65,1 thousand Total current assets: $2,1 million Total current liabilities: $879,1 thousand Revenues: $361,1 thousand Net loss: $580,1 thousand In the press release from August 15, BRGO... more

Puramed Bioscience, Inc. (PMBS) Back To Triple Zero Bottom

Thumbnail
Puramed Bioscience, Inc. (PMBS) ended last week with a slide down, lowering the price back to the $0.0001 mark. PMBS's efforts have had no success in maintaining a long-lasting interest in the company. The price of PMBS' stock has been low throughout recent events. The announcements about the company's plans for future development have been insufficient to halt the decline. PMBS' downfall began after an 8-K issued on July 11 reported about a number of decisions that shareholders seemingly did not approve... more

mPhase Technologies, Inc. (XDSL) Sinks Further Down

Thumbnail
The efforts mPhase Technologies, Inc. (XDSL) has made to attract investors' interest lately have had no reaction on the market. XDSL recently reported a growth in revenues in the last quarter of its fiscal year ended June 30, 2014. The company stated in a press release issued on August 5 that its revenues have grown by approximately 6% compared to the previous quarter. We can take a look at XDSL's 10-Q for the period ended March 31, 2014 to see what this would translate into: Cash: $87,4 thousand Total... more
First 1 2 3 4 5 6 7 8 9 10 >> Last